Cargando…

The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells

Background: Pyocyanin (PCN), a highly pathogenic pigment produced by Pseudomonas aeruginosa, induces caspase 3-dependent human B cell (Raji cells) death. The aim of the present study, therefore, was to assess whether antigen-specific IgY antibodies may be protective on PCN-induced Raji cell death. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Susilowati, Heni, Artanto, Sidna, Yulianto, Heribertus Dedy Kusuma, Sosroseno, Wihaskoro, Hutomo, Suryani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971839/
https://www.ncbi.nlm.nih.gov/pubmed/32025288
http://dx.doi.org/10.12688/f1000research.19327.2
_version_ 1783489793629356032
author Susilowati, Heni
Artanto, Sidna
Yulianto, Heribertus Dedy Kusuma
Sosroseno, Wihaskoro
Hutomo, Suryani
author_facet Susilowati, Heni
Artanto, Sidna
Yulianto, Heribertus Dedy Kusuma
Sosroseno, Wihaskoro
Hutomo, Suryani
author_sort Susilowati, Heni
collection PubMed
description Background: Pyocyanin (PCN), a highly pathogenic pigment produced by Pseudomonas aeruginosa, induces caspase 3-dependent human B cell (Raji cells) death. The aim of the present study, therefore, was to assess whether antigen-specific IgY antibodies may be protective on PCN-induced Raji cell death. Methods: Chickens were subcutaneously immunized with Freund's complete adjuvant containing PCN, and then given two boosted immunizations.  Anti-PCN IgY antibodies were purified from egg yolk and detected using an agar gel precipitation test (AGPT) and ELISA. Protective effects of antigen-specific IgY on Raji cells were tested using a cell viability assay. Results: AGPT results showed the formation of strong immune complex precipitates, whilst ELISA further confirmed the presence of IgY antibodies specific to PCN at significant concentration. Further experiments showed that anti-PCN IgY antibodies significantly increased PCN-treated Raji cell viability in a dose-dependent fashion (p<0.05). Conclusions: The results of the present study suggest that anti-PCN IgY antibodies may be protective on PCN-induced Raji cell death.
format Online
Article
Text
id pubmed-6971839
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-69718392020-02-04 The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells Susilowati, Heni Artanto, Sidna Yulianto, Heribertus Dedy Kusuma Sosroseno, Wihaskoro Hutomo, Suryani F1000Res Research Article Background: Pyocyanin (PCN), a highly pathogenic pigment produced by Pseudomonas aeruginosa, induces caspase 3-dependent human B cell (Raji cells) death. The aim of the present study, therefore, was to assess whether antigen-specific IgY antibodies may be protective on PCN-induced Raji cell death. Methods: Chickens were subcutaneously immunized with Freund's complete adjuvant containing PCN, and then given two boosted immunizations.  Anti-PCN IgY antibodies were purified from egg yolk and detected using an agar gel precipitation test (AGPT) and ELISA. Protective effects of antigen-specific IgY on Raji cells were tested using a cell viability assay. Results: AGPT results showed the formation of strong immune complex precipitates, whilst ELISA further confirmed the presence of IgY antibodies specific to PCN at significant concentration. Further experiments showed that anti-PCN IgY antibodies significantly increased PCN-treated Raji cell viability in a dose-dependent fashion (p<0.05). Conclusions: The results of the present study suggest that anti-PCN IgY antibodies may be protective on PCN-induced Raji cell death. F1000 Research Limited 2019-12-17 /pmc/articles/PMC6971839/ /pubmed/32025288 http://dx.doi.org/10.12688/f1000research.19327.2 Text en Copyright: © 2019 Susilowati H et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Susilowati, Heni
Artanto, Sidna
Yulianto, Heribertus Dedy Kusuma
Sosroseno, Wihaskoro
Hutomo, Suryani
The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
title The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
title_full The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
title_fullStr The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
title_full_unstemmed The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
title_short The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
title_sort protective effects of antigen-specific igy on pyocyanin-treated human lymphoma raji cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971839/
https://www.ncbi.nlm.nih.gov/pubmed/32025288
http://dx.doi.org/10.12688/f1000research.19327.2
work_keys_str_mv AT susilowatiheni theprotectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT artantosidna theprotectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT yuliantoheribertusdedykusuma theprotectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT sosrosenowihaskoro theprotectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT hutomosuryani theprotectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT susilowatiheni protectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT artantosidna protectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT yuliantoheribertusdedykusuma protectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT sosrosenowihaskoro protectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells
AT hutomosuryani protectiveeffectsofantigenspecificigyonpyocyanintreatedhumanlymphomarajicells